These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 34634841)
1. Epitranscriptomic modifications in acute myeloid leukemia: m Pauli C; Kienhöfer M; Göllner S; Müller-Tidow C Biol Chem; 2021 Nov; 402(12):1531-1546. PubMed ID: 34634841 [TBL] [Abstract][Full Text] [Related]
2. Functions of N6-methyladenosine (m6A) RNA modifications in acute myeloid leukemia. Fang Z; Ding H; Han J; Fu L; Jin J; Feng W J Leukoc Biol; 2024 Oct; 116(4):662-671. PubMed ID: 38721720 [TBL] [Abstract][Full Text] [Related]
3. The N6-methyladenosine RNA modification in acute myeloid leukemia. Yankova E; Aspris D; Tzelepis K Curr Opin Hematol; 2021 Mar; 28(2):80-85. PubMed ID: 33337619 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia. Huang S; Jiang MM; Chen GF; Qian K; Gao HH; Guan W; Shi JL; Liu AQ; Liu J; Wang BH; Li YH; Yu L Chin Med J (Engl); 2016 Jun; 129(11):1355-62. PubMed ID: 27231175 [TBL] [Abstract][Full Text] [Related]
5. N6-Methyladenosine Role in Acute Myeloid Leukaemia. Ianniello Z; Fatica A Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096915 [TBL] [Abstract][Full Text] [Related]
6. [Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia]. Wen Y; Fang S; Yang J; Wang H; Jiao Y; Wang N; Wei Y; Wang L; Dou L Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):690-697. PubMed ID: 35673912 [TBL] [Abstract][Full Text] [Related]
7. FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N Li Z; Weng H; Su R; Weng X; Zuo Z; Li C; Huang H; Nachtergaele S; Dong L; Hu C; Qin X; Tang L; Wang Y; Hong GM; Huang H; Wang X; Chen P; Gurbuxani S; Arnovitz S; Li Y; Li S; Strong J; Neilly MB; Larson RA; Jiang X; Zhang P; Jin J; He C; Chen J Cancer Cell; 2017 Jan; 31(1):127-141. PubMed ID: 28017614 [TBL] [Abstract][Full Text] [Related]
8. Nucleophosmin 1: from its pathogenic role to a tantalizing therapeutic target in acute myeloid leukemia. Shi Y; Xue Y; Wang C; Yu L Hematology; 2022 Dec; 27(1):609-619. PubMed ID: 35621728 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in the reciprocal regulation of m Yang J; Liang F; Zhang F; Zhao H; Gong Q; Gao N Pharmacol Ther; 2024 Jul; 259():108671. PubMed ID: 38830387 [TBL] [Abstract][Full Text] [Related]
10. N6-methyladenosine RNA modifications: a potential therapeutic target for AML. Hu R; Liao P; Xu B; Qiu Y; Zhang H; Li Y Ann Hematol; 2024 Aug; 103(8):2601-2612. PubMed ID: 37548690 [TBL] [Abstract][Full Text] [Related]
11. The m Yen YP; Chen JA J Biomed Sci; 2021 May; 28(1):40. PubMed ID: 34039354 [TBL] [Abstract][Full Text] [Related]
12. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617 [TBL] [Abstract][Full Text] [Related]
13. Neratinib impairs function of m6A recognition on AML1-ETO pre-mRNA and induces differentiation of t (8;21) AML cells by targeting HNRNPA3. Liu Y; Zheng L; Li Y; Ma L; Zheng N; Liu X; Zhao Y; Yu L; Liu N; Liu S; Zhang K; Zhou J; Wei M; Yang C; Yang G Cancer Lett; 2024 Jul; 594():216980. PubMed ID: 38797229 [TBL] [Abstract][Full Text] [Related]
14. HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia. Zhu G; Luo H; Feng Y; Guryanova OA; Xu J; Chen S; Lai Q; Sharma A; Xu B; Zhao Z; Feng R; Ni H; Claxton D; Guo Y; Mesa RA; Qiu Y; Yang FC; Li W; Nimer SD; Huang S; Xu M Nat Commun; 2021 Mar; 12(1):1956. PubMed ID: 33782403 [TBL] [Abstract][